Elekta showcases a radiotherapy milestone with the 5,000th linear accelerator assembled at our Crawley, England facility. In addition to being a prolific manufacturer of this life-changing technology, we are a leading innovator, pushing the boundaries of precision radiation medicine. We’re confident we will continue focusing on technological breakthroughs that will benefit individuals with cancer.
Brachytherapy is a growing treatment modality and is commonly used for many indications such as gynecology, prostate, breast, head & neck, skin and rectal. Brachytherapy is suited as a single modality or in combination with other treatments. For example, early stage prostate cancer can be indicated for brachytherapy as a single modality or as a boost after external beam radiation therapy for gynecological cancers. With more than 40 years of experience, Elekta can offer you a complete range of brachytherapy solutions supporting your brachytherapy practice. Our key technological advances have resulted in an integrated package of treatment planning and delivery systems. We believe that our solutions, services and extensive knowledge of precisely targeted brachytherapy can play a vital role in treating cancer successfully.
Elekta Care™ is our comprehensive services program designed to support you throughout your entire Elekta experience. Elekta Care encompasses all services we provide — including service and support, education and training and consultative services.
Stereotactic radiosurgery was first developed in 1949 by Swedish neurosurgeon Lars Leksell. With the Leksell Stereotactic System®, physicians could treat small targets in the brain that were not amenable to conventional surgery. That led to development of Leksell Gamma Knife® – the benchmark for high accuracy cranial radiosurgery. Since then, the technology has dramatically evolved. The latest generation Gamma Knife technology is Leksell Gamma Knife® Icon™. Watch what neurosurgeons and radiation oncologist have to say about Icon.
Stereotactic neurosurgery was first developed in 1949 by Swedish Professor Lars Leksell, and Elekta has helped to dramatically evolve the technology. With stereotaxy, physicians can treat small targets in the brain that are not amenable to conventional surgery. The latest generation of Elekta’s stereotactic system, Leksell® Vantage™ stereotactic system, is based on the proven Leksell principles and designed to meet the need for better imaging, workflow and patient comfort.
Elekta's human-centric software creates an efficient clinical environment in which all activities related to patient care - from diagnosis and treatment to follow-up - are as streamlined as possible, giving clinicians more time to focus on patients. Elekta's open systems and vendor-neutral connectivity ensure cross-platform flexibility to integrate the most advanced and useful tools. Oncology departments worldwide recognize Elekta Software's unique, comprehensive offerings, with 100,000 patients annually receiving diagnosis, treatment or follow-up facilitated by Elekta solutions.
Videos from around YouTube of our customers using Elekta Equipment. The statements and opinions expressed on these videos are solely those of their respective authors and do not necessarily reflect the views, nor are they endorsed by Elekta, and its licensors do not guarantee the accuracy of, and are in no way responsible for any content on these videos.